Excimer laser and stenting in patients with distal peripheral arterial disease: a review of the clinical effectiveness, safety, and guidelines
CADTH
Record ID 32016000124
English
Authors' recommendations:
There remains a paucity of good quality evidence on the effectiveness of excimer laser atherectomy for the treatment of distal peripheral arterial disease. While most of the included studies provided some evidence of the procedural success and clinical effectiveness of excimer laser atherectomy (as adjunctive treatment to PTA in most cases), the lack of partitioned reporting in most studies was problematic for accurate interpretation (as interventions or lesion locations were often grouped when results were reported). There was limited generalizability as the patient population was primarily high-risk with chronic, if not severe, limb ischemia. In addition, there was the potential for both selection and intervention bias in the included studies, and most of the studies had small sample sizes. Therefore, results need to be interpreted with caution. No evidence-based guidelines were identified that were associated with excimer laser and stenting in adult patients with distal peripheral arterial disease.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.cadth.ca/sites/default/files/pdf/htis/jan-2015/RC0630%20Excimer%20Laser%20in%20DPAD%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
Canada
MeSH Terms
- Atherosclerosis
- Laser Therapy
- Lasers
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Vascular Patency
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.